Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF | T.LABS.W.B

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:LABS)

MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement

PR Newswire 6 days ago

MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million

PR Newswire September 5, 2023

Study examines cannabis' impact on anxiety, depression in fibromyalgia patients

Jon Brown August 31, 2023

MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients

PR Newswire August 31, 2023

MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth

PR Newswire August 14, 2023

MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results

PR Newswire August 10, 2023

MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status

PR Newswire August 1, 2023

MediPharm Labs Announces Change of Auditor

PR Newswire June 22, 2023

MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA

Canada NewsWire May 15, 2023
View More News ››

Opinion & Analysis (TSX:LABS)

The 2019 Benzinga Cannabis Capital Conference: Everything You Missed In Miami Beach

Hannah Genig April 1, 2019

Medipharm Labs: First Canadian LP Licensed Exclusively for Extraction

Stockhouse Editorial September 5, 2018
View More Opinion ››

Bullboard Posts (TSX:LABS)

Will Jazz v Avadel case law help Labs Global Pharma Co

 Going down the deep legal rabbit hole for generic hopefuls https://www.nytimes.com/2023/02/28/business/jazz-narcolepsy-avadel...
mdjbrown - 11 minutes ago

RE:RE:RE:Will the Epidiolex exclusivity doors get kicked wide open

sorry s1i, yes, I meant to reference their ANDA filed to the FDA by a global pharma co in Sept 22, 2022 not a 505(b) The one thing we...
mdjbrown - 35 minutes ago

RE:RE:RE:RE:Will the Epidiolex exclusivity doors get kicked wide open

Yes, that was typo, should have read Sept 2022 and in a 2020 LABS press release they already mentioned scientific data/evidence where...
subaru1i - 40 minutes ago

RE:RE:RE:Will the Epidiolex exclusivity doors get kicked wide open

You are welcome s1i, and it could be very possible Medipharm has more than one FDA iron in the fire. My assumption for Labs and their...
mdjbrown - 1 hour ago

CBD

/ SCIENCE & HEALTH ...
Danno13 - 3 hours ago

RE:RE:Will the Epidiolex exclusivity doors get kicked wide open

Thank you mdjbrown.  So the 505(b) submitted by LABS the way I understand it is a completely new drug entity or NCE, new chemical...
subaru1i - 3 hours ago
View more Bullboard ››

Numinus Wellness Inc

Numinus Wellness Inc

Numinus Wellness Inc. (Numinus) is a Canada-based mental health care company. The Company develops proprietary, psychedelic ...
View More »